Tiago Carvalho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tiago Carvalho has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Artur Mendes
Nephrology Department, Unidade Local de Saúde de Lisboa Ocidental, Carnaxide, Lisbon, Portugal
2 shared publications- Maria Inês Roxo
Department of Nephrology, Hospital Santa Cruz, Unidade Local de Saúde de Lisboa Ocidental, Carnaxide, Portugal
2 shared publications Rita Birne
Nephrology Department, Unidade Local de Saúde de Lisboa Ocidental, Carnaxide, Lisbon, Portugal
2 shared publications- Rita Veríssimo
Nephrology, Centro Hospitalar Lisboa Ocidental, Lisbon, PRT
2 shared publications Ana Rita Martins
Nephrology, Centro Hospitalar de Lisboa Ocidental EPE, Lisboa, Portugal
1 shared publication- Andreia Carnevale
Centro Hospitalar Lisboa Ocidental, Portugal
1 shared publication
Latest Publications
- 25 March 2026
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 27 (5) , 2391-2396
Right intra-atrial haemodialysis catheter insertion via sternotomy with intrathoracic graft placement: A case report
Haemodialysis requires maintenance of a functioning access to the bloodstream. In patients with exhaustion of vascular access, this may pose significant challenges, and alternative last-resort sites for placement of central venous catheters might be needed. We report a case of vascular access exhaustion, with several anomalies of central venous drainage and failure of multiple arteriovenous accesses. This patient was proposed for an unconventional trans-atrial catheter placement via sternotomy with an intrathoracic graft. The catheter was successfully used for over 18 months, which reinforces that this can be a viable approach when other methods have failed.
- 25 March 2026
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 27 (5) , 2391-2396
Right intra-atrial haemodialysis catheter insertion via sternotomy with intrathoracic graft placement: A case report
Haemodialysis requires maintenance of a functioning access to the bloodstream. In patients with exhaustion of vascular access, this may pose significant challenges, and alternative last-resort sites for placement of central venous catheters might be needed. We report a case of vascular access exhaustion, with several anomalies of central venous drainage and failure of multiple arteriovenous accesses. This patient was proposed for an unconventional trans-atrial catheter placement via sternotomy with an intrathoracic graft. The catheter was successfully used for over 18 months, which reinforces that this can be a viable approach when other methods have failed.
- 7 March 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (3) , e264594
Urogenital tuberculosis in a patient with persistent sterile pyuria
Urogenital tuberculosis (UGTB) can be a challenging diagnosis, and a delay in treatment may lead to irreversible organ damage. We report the case of a Guinean man in his 40s, residing in Portugal, who presented with lower urinary tract symptoms, urethral discharge and a right scrotal mass. Laboratory results revealed acute kidney injury, hypercalcaemia and persistent sterile pyuria, and ultrasound findings were suggestive of orchiepididymitis. Interferon gamma release assay was positive, as were the urine cultures for Mycobacterium tuberculosis, confirming the diagnosis of UGTB. The patient was initiated on tuberculostatic drugs, with a favourable response. This case emphasises the high degree of suspicion needed to establish the diagnosis of UGTB, which should be considered in patients with persistent sterile pyuria and a relevant epidemiological context.
- 7 March 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (3) , e264594
Urogenital tuberculosis in a patient with persistent sterile pyuria
Urogenital tuberculosis (UGTB) can be a challenging diagnosis, and a delay in treatment may lead to irreversible organ damage. We report the case of a Guinean man in his 40s, residing in Portugal, who presented with lower urinary tract symptoms, urethral discharge and a right scrotal mass. Laboratory results revealed acute kidney injury, hypercalcaemia and persistent sterile pyuria, and ultrasound findings were suggestive of orchiepididymitis. Interferon gamma release assay was positive, as were the urine cultures for Mycobacterium tuberculosis, confirming the diagnosis of UGTB. The patient was initiated on tuberculostatic drugs, with a favourable response. This case emphasises the high degree of suspicion needed to establish the diagnosis of UGTB, which should be considered in patients with persistent sterile pyuria and a relevant epidemiological context.
- Open Access
- 11 January 2023
- Published by Springer Nature in Cureus
- Vol. 15 (1) , e33670
Hand-Foot-Mouth Disease in an Adult
Hand-foot-mouth syndrome is a common childhood illness. Although occurrence in adults is rare, its incidence has been increasing. In such cases, it usually presents with atypical symptoms. The authors present the case of a 33-year-old male patient who presented with constitutional symptoms, feverish sensation, and macular palmoplantar rash associated with oral and oropharynx ulcers. The epidemiological history revealed exposure to two cohabitants (children) with a recent diagnosis of hand-foot-mouth disease (HFMD).
- 11 January 2023
- Published by Springer Nature in Cureus
- Vol. 15 (1) , e33670
Open AccessHand-Foot-Mouth Disease in an Adult
Hand-foot-mouth syndrome is a common childhood illness. Although occurrence in adults is rare, its incidence has been increasing. In such cases, it usually presents with atypical symptoms. The authors present the case of a 33-year-old male patient who presented with constitutional symptoms, feverish sensation, and macular palmoplantar rash associated with oral and oropharynx ulcers. The epidemiological history revealed exposure to two cohabitants (children) with a recent diagnosis of hand-foot-mouth disease (HFMD).
- 31 March 2022
- Published by Publicacoes Ciencia e Vida, Lda in Portuguese Journal of Nephrology & Hypertension
- Vol. 35 (1) , 40-45
Early mortality in incident hemodialysis patients – A retrospective case-control study
Introduction: Chronic kidney disease has significant morbidity and mortality worldwide. Various studies have demonstrated that incident patients experience a higher mortality rate within the first 3 months of dialysis. Methods: A single-center retrospective case-control study (1:3) was performed to determine early (<90 days) mortality rate and associated risk factors in incident hemodialysis patients from January 2013 to December 2018. We compared variables between survivors and non-survivors at 90 days after initiation of hemodialysis. Multivariate logistic regression was used to calculate the adjusted odds ratio with 95% confidence intervals for the variables associated with early mortality and a predictive model was developed. Results: From a total of 626 incident hemodialysis patients, 48 (7.7%) died before 90 days of treatment. Non-survivors were older [OR 1.07 (1.03-1.11)], had higher rates of non-recovering acute kidney injury [OR 7.91 (3.63- 17.24)], emergency start of hemodialysis [OR 4.31 (2.15-8.62)], congestive heart failure [OR 5.68 (2.81-11.48)], ischemic cardiomyopathy [OR 4.50 (2.25-8.99)], chronic obstructive pulmonary disease [OR 3.60 (1.44-8.95)], Charlson comorbidity index [OR 1.47 (1.27-1.70)] and dependence of assistance in daily living activities [OR 3.46 (1.76-6.82)]. Patients were less likely to have 90-day mortality if they had nephrologist appointments at least 90 days prior to end-stage renal disease [OR 0.25, 95% CI (0.13-0.50); p<0.001] or a higher serum albumin [OR 0.34, 95% CI (0.19-0.62); p<0.001]. Multivariate analysis risk factors independently associated with early mortality were older age [aOR 1.06 (1-01-1.10), p=0.022], acute kidney injury as cause of end-stage renal disease [aOR 12.62 (4.50-35.40), p<0.001], congestive heart failure [aOR 3.79 (1.58-9.11), p=0.003], and Charlson comorbidity index [aOR 1.30 (1.09-1.56), p=0.005]. The model showed very good discriminative ability [AUROC (95% CI) 0.88 (0.83-0.94)]. Conclusion: Early mortality occurred in 7.7% of our population. Our model could be used to identify patients at higher risk of death during the first 90 days of hemodialysis and aid informed decision-making regarding end-stage renal disease treatment options.
- 31 March 2022
- Published by Publicacoes Ciencia e Vida, Lda in Portuguese Journal of Nephrology & Hypertension
- Vol. 35 (1) , 40-45
Early mortality in incident hemodialysis patients – A retrospective case-control study
Introduction: Chronic kidney disease has significant morbidity and mortality worldwide. Various studies have demonstrated that incident patients experience a higher mortality rate within the first 3 months of dialysis. Methods: A single-center retrospective case-control study (1:3) was performed to determine early (<90 days) mortality rate and associated risk factors in incident hemodialysis patients from January 2013 to December 2018. We compared variables between survivors and non-survivors at 90 days after initiation of hemodialysis. Multivariate logistic regression was used to calculate the adjusted odds ratio with 95% confidence intervals for the variables associated with early mortality and a predictive model was developed. Results: From a total of 626 incident hemodialysis patients, 48 (7.7%) died before 90 days of treatment. Non-survivors were older [OR 1.07 (1.03-1.11)], had higher rates of non-recovering acute kidney injury [OR 7.91 (3.63- 17.24)], emergency start of hemodialysis [OR 4.31 (2.15-8.62)], congestive heart failure [OR 5.68 (2.81-11.48)], ischemic cardiomyopathy [OR 4.50 (2.25-8.99)], chronic obstructive pulmonary disease [OR 3.60 (1.44-8.95)], Charlson comorbidity index [OR 1.47 (1.27-1.70)] and dependence of assistance in daily living activities [OR 3.46 (1.76-6.82)]. Patients were less likely to have 90-day mortality if they had nephrologist appointments at least 90 days prior to end-stage renal disease [OR 0.25, 95% CI (0.13-0.50); p<0.001] or a higher serum albumin [OR 0.34, 95% CI (0.19-0.62); p<0.001]. Multivariate analysis risk factors independently associated with early mortality were older age [aOR 1.06 (1-01-1.10), p=0.022], acute kidney injury as cause of end-stage renal disease [aOR 12.62 (4.50-35.40), p<0.001], congestive heart failure [aOR 3.79 (1.58-9.11), p=0.003], and Charlson comorbidity index [aOR 1.30 (1.09-1.56), p=0.005]. The model showed very good discriminative ability [AUROC (95% CI) 0.88 (0.83-0.94)]. Conclusion: Early mortality occurred in 7.7% of our population. Our model could be used to identify patients at higher risk of death during the first 90 days of hemodialysis and aid informed decision-making regarding end-stage renal disease treatment options.
- 18 January 2021
- Published by BMJ in BMJ Case Reports
- Vol. 14 (1) , e238097
Novel SLC12A3 mutation in Gitelman syndrome
Gitelman syndrome (GS) is an autosomal recessive disease characterised by the presence of hypokalaemic metabolic alkalosis with hypomagnesaemia and hypocalciuria. The prevalence of this disease is 1–10/40 000. GS is usually associated with mild and non-specific symptoms and many patients are only diagnosed in adulthood. The disease is caused by mutations in the SLC12A3 gene. We present the case of a 49-year-old man referred to a nephrology appointment due to persistent hypokalaemia and hypomagnesaemia. Complementary evaluation revealed hypokalaemia, hypomagnesaemia, metabolic alkalosis, hyperreninaemia, increased chloride and sodium urinary excretion, and reduced urinary calcium excretion. Renal function, remainder serum and urinary ionogram, and renal ultrasound were normal. A diagnosis of GS was established and confirmed with genetic testing which revealed a novel mutation in SLC12A3 (c.1072del, p.(Ala358Profs*12)). This novel mutation extends the spectrum of known SLC12A3 gene mutations and further supports the allelic heterogeneity of GS.
- 18 January 2021
- Published by BMJ in BMJ Case Reports
- Vol. 14 (1) , e238097
Novel SLC12A3 mutation in Gitelman syndrome
Gitelman syndrome (GS) is an autosomal recessive disease characterised by the presence of hypokalaemic metabolic alkalosis with hypomagnesaemia and hypocalciuria. The prevalence of this disease is 1–10/40 000. GS is usually associated with mild and non-specific symptoms and many patients are only diagnosed in adulthood. The disease is caused by mutations in the SLC12A3 gene. We present the case of a 49-year-old man referred to a nephrology appointment due to persistent hypokalaemia and hypomagnesaemia. Complementary evaluation revealed hypokalaemia, hypomagnesaemia, metabolic alkalosis, hyperreninaemia, increased chloride and sodium urinary excretion, and reduced urinary calcium excretion. Renal function, remainder serum and urinary ionogram, and renal ultrasound were normal. A diagnosis of GS was established and confirmed with genetic testing which revealed a novel mutation in SLC12A3 (c.1072del, p.(Ala358Profs*12)). This novel mutation extends the spectrum of known SLC12A3 gene mutations and further supports the allelic heterogeneity of GS.
- 29 January 2019
- Published by BMJ in BMJ Case Reports
- Vol. 12 (1) , e227688
Tubulointerstitial nephritis and uveitis syndrome in a female adult
Tubulointerstitial nephritis and uveitis (TINU) syndrome is a rare disease characterised by the association of acutetubulointerstitial nephritis and uveitis. It affects mainly children and young women. Drugs and infections may be precipitating factors. It is a diagnosis of exclusion. The mainstays of treatment are topical and systemic corticosteroids. Prognosis is usually favourable. We report a case of TINU which occurred in our unit. A 37-year-old woman presented with an influenza-like illness, bilateral ocular pain and blurred vision. Ophthalmological evaluation revealed bilateral anterior uveitis and later renal involvement was seen as acute tubulointerstitial nephritis. A diagnosis of TINU was assumed after exclusion of other systemic diseases. She was treated with topical corticosteroids for the uveitis and evolved favourably, with resolution of ocular symptoms and normalisation of serum creatinine and proteinuria. This case highlights the importance of a high degree of clinical suspicion to make the diagnosis of TINU syndrome.
- 29 January 2019
- Published by BMJ in BMJ Case Reports
- Vol. 12 (1) , e227688
Tubulointerstitial nephritis and uveitis syndrome in a female adult
Tubulointerstitial nephritis and uveitis (TINU) syndrome is a rare disease characterised by the association of acutetubulointerstitial nephritis and uveitis. It affects mainly children and young women. Drugs and infections may be precipitating factors. It is a diagnosis of exclusion. The mainstays of treatment are topical and systemic corticosteroids. Prognosis is usually favourable. We report a case of TINU which occurred in our unit. A 37-year-old woman presented with an influenza-like illness, bilateral ocular pain and blurred vision. Ophthalmological evaluation revealed bilateral anterior uveitis and later renal involvement was seen as acute tubulointerstitial nephritis. A diagnosis of TINU was assumed after exclusion of other systemic diseases. She was treated with topical corticosteroids for the uveitis and evolved favourably, with resolution of ocular symptoms and normalisation of serum creatinine and proteinuria. This case highlights the importance of a high degree of clinical suspicion to make the diagnosis of TINU syndrome.
- 1 November 2018
- Published by BMJ in BMJ Case Reports
- Vol. 11 (1) , e227713
Chryseobacterium indologenes peritonitis in a peritoneal dialysis patient
Peritonitis remains an important complication of peritoneal dialysis. The Gram-negative bacillus Chryseobacterium indologenes causes infection mostly in immunocompromised patients with severe underlying disease, mainly in Asia. Herein, we report the first case in Europe and the second case in an immunocompetent patient of peritoneal dialysis-associated C. indologenes peritonitis. Our patient presented with abdominal pain and a cloudy effluent and was started on intraperitoneal antibiotics. The organism cultured from the peritoneal fluid was later identified as C. indologenes and antibiotic therapy was adjusted accordingly. Despite this, the peritonitis followed a relapsing course, requiring Tenckhoff catheter removal, temporary transfer to haemodialysis and intravenous antibiotics. Subsequently, a new Tenckhoff catheter was inserted and peritoneal dialysis was restarted. The patient remains peritonitis free after 18 months of follow-up. This case highlights the need to consider rare causes of peritonitis in peritoneal dialysis patients as well as the heterogeneous clinical course of C. indologenes peritonitis.
- 1 November 2018
- Published by BMJ in BMJ Case Reports
- Vol. 11 (1) , e227713
Chryseobacterium indologenes peritonitis in a peritoneal dialysis patient
Peritonitis remains an important complication of peritoneal dialysis. The Gram-negative bacillus Chryseobacterium indologenes causes infection mostly in immunocompromised patients with severe underlying disease, mainly in Asia. Herein, we report the first case in Europe and the second case in an immunocompetent patient of peritoneal dialysis-associated C. indologenes peritonitis. Our patient presented with abdominal pain and a cloudy effluent and was started on intraperitoneal antibiotics. The organism cultured from the peritoneal fluid was later identified as C. indologenes and antibiotic therapy was adjusted accordingly. Despite this, the peritonitis followed a relapsing course, requiring Tenckhoff catheter removal, temporary transfer to haemodialysis and intravenous antibiotics. Subsequently, a new Tenckhoff catheter was inserted and peritoneal dialysis was restarted. The patient remains peritonitis free after 18 months of follow-up. This case highlights the need to consider rare causes of peritonitis in peritoneal dialysis patients as well as the heterogeneous clinical course of C. indologenes peritonitis.